30
Participants
Start Date
April 30, 2011
Primary Completion Date
October 31, 2013
Study Completion Date
October 31, 2014
RAD001: Everolimus
10 mg of RAD001 will be self-administered orally once daily continuously for one year or until unacceptable toxicity or discontinuation from the study from any other reason.
Henri Mondor Hospital, Créteil
Collaborators (1)
Novartis
INDUSTRY
Assistance Publique - Hôpitaux de Paris
OTHER